Because the patient had no family history of inflammatory bowel disease, the presentation was atypical and the only significant aspect was the concomitant chronic plaque psoriasis controlled with an IL-17 inhibitor; the final diagnosis was drug-associated colitis in the context of biologic therapy with ixekizumab [66]. This evidence concerns the gene IL17A and inflammatory bowel disease.